Pharmaceuticals [1]
Over the past decade, Novartis Pharmaceuticals Canada has introduced 20 new medicines that have had an important impact on patients suffering from a wide variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation and osteoporosis.
A [2]
Aclasta* (zoledronic acid injection)
Bone Metabolism Regulator
Important information for healthcare professionals (2010) [5]
Public Communication (2010) [6]
Important information for healthcare professionals (2005) [7]
Public Communication (2005) [8]
*Aclasta is a registered trademark
Afinitor* / Afinitor* DISPERZ** (everolimus tablets)
mTOR Kinase Inhibitor
Product Monograph [10]
*Afinitor is a registered trademark **DISPERZ is a trademark
Aimovig* (erenumab)
Anti-Calcitonin gene-related peptide receptor (anti-CGRPR)
Patient Medication Information [11]
Product Monograph [12]
*AIMOVIG is a trademark of Amgen Inc. used under license by Novartis Pharmaceuticals Canada Inc.
Alomide* (Lodoxamide)
Anti-allergy Agent
Consumer Information [13]
Product Monograph [14]
*Alomide is a trademark of Novartis
Atectura* Breezhaler* (Indacaterol (as acetate)/mometasone furoate inhalation powder)
Bronchodilator and Inhaled Corticosteroid
Patient Medication Information [15]
Product Monograph [16]
*ATECTURA and BREEZHALER are registered trademarks
Atriance* (Nelarabine Injection)
Antineoplastic Agent
Consumer Information [17]
Product Monograph [18]
*ATRIANCE is a registered trademark
Azarga* (brinzolamide and timolol)
Topical Carbonic Anhydrase Inhibitor and Topical Beta-Adrenergic Blocking Agent
Consumer Information [19]
Product Monograph [20]
*Azarga is a Novartis product
Azopt* (Brinzolamide Ophthalmic Suspension)
Topical Carbonic Anhydrase Inhibitor
Consumer Information [21]
Product Monograph [22]
*Azopt is a trademark of Novartis
B [23]
Beovu* (brolucizumab injection)
Ophthalmological / Antineovascularisation agent
Consumer Information [24]
Product Monograph [25]
*BEOVU is a registered trademark
Betoptic S* (Betaxolol Hydrochloride Ophthalmic Suspension)
Antiglaucoma Agent (Ophthalmic)
Consumer Information [26]
Product Monograph [27]
*a trademark of Novartis
C [28]
Ciloxan* (ciprofloxacin hydrochloride)
Antibacterial Agent
Product Monograph [29]
Patient Medication Information (Ointment) [30]
Patient Medication Information (solution) [31]
*Ciloxan is a trademark of Novartis
CiproDex* (Ciprofloxacin /Dexamethasone Otic Suspension)
Antibacterial - Corticosteroid (Otic)
Consumer Information [32]
Product Monograph [33]
*a trademark of Novartis
Comtan* (entacapone)
COMT-Inhibitor
Consumer Information [34]
Product Monograph [35]
*Comtan is a registered trademark
Cosentyx* (secukinumab)
Biological Response Modifier
Consumer Information [36]
Product Monograph [37]
*COSENTYX and SensoReady are registered trademarks
D [38]
Desferal* (deferoxamine mesylate for injection)
Iron and Aluminum Chelating Agent
Consumer Information [39]
Product Monograph [40]
*Desferal is a registered trademark
Diovan* (valsartan)
Angiotensin II AT1 Receptor Blocker
Consumer Information [41]
Product Monograph [42]
*Diovan is a registered trademark
Diovan*-HCT (valsartan and hydrochlorothiazide)
Angiotensin II AT1 Receptor Blocker and Diuretic
Consumer Information [43]
Product Monograph [44]
*Diovan is a registered trademark
DuoTrav PQ* (travoprost/timolol)
Prostaglandin F2a analogue and beta-adrenergic receptor blocker
Consumer Information [45]
Product Monograph [46]
*DuoTrav is a trademark of Novartis
Durezol* (difluprednate)
Topical Corticosteroid
Consumer Information [47]
Product Monograph [48]
*Durezol is a Novartis product
E [49]
Enerzair* Breezhaler* (Indacaterol (as acetate) / glycopyrronium (as bromide) / mometasone furoate inhalation powder)
Bronchodilator and Inhaled Corticosteroid
Patient Medication Information [50]
Product Monograph [51]
*ENERZAIR and BREEZHALER are registered trademarks
Entresto* (sacubitril/valsartan)
Neutral endopeptidase inhibitor/Angiotensin II AT1 receptor blocker
Product Monograph [52]
Patient Medication Information [53]
*ENTRESTO is a trademark
Estalis* (norethindrone acetate and estradiol-17ß)
Progestin-Estrogen
Consumer Information [54]
Product Monograph [55]
*Estalis is a registered trademark
Estradot* (estradiol-17ß)
Estrogen
Consumer Information [56]
Product Monograph [57]
*Estradot is a registered trademark
Exelon* (rivastigmine hydrogen tartrate)
Cholinesterase Inhibitor
Consumer Information [58]
Product Monograph [59]
Important information for healthcare professionals (2001) [60]
*Exelon is a registered trademark
Exelon* Patch (rivastigmine transdermal patch)
Cholinesterase Inhibitor
Consumer Information [61]
Product Monograph [62]
Important information for healthcare professionals (2010) [63]
Public Communication (2010) [64]
*Exelon is a registered trademark
Exjade* (deferasirox)
Iron Chelating Agent
Consumer Information [65]
Product Monograph [66]
Important information for healthcare professionals (2009) [67]
Public Communication (2009) [68]
Important information for healthcare professionals (2008) [69]
Public Communication (2008) [70]
Important information for healthcare professionals (2007) [71]
Public Communication (2007) [72]
*Exjade is a registered trademark
Extavia* (Interferon beta-1b)
Immunomodulator
Consumer Information [73]
Product Monograph [74]
*Extavia is a registered trademark
F [75]
Famvir* (famciclovir)
Antiviral Agent
Consumer Information [76]
Product Monograph [77]
*Famvir is a registered trademark
Femara* (letrozole)
Non-steroidal aromatase inhibitor; Inhibitor of estrogen biosynthesis; Anti-tumour agent
Consumer Information [78]
Product Monograph [79]
Important information for healthcare professionals (2006) [80]
Important information for healthcare professionals (2005) [81]
Public Communication (2005) [82]
*Femara is a registered trademark
Flarex* (Fluorometholone Acetate)
Corticosteroid
Consumer Information [83]
Product Monograph [84]
*Flarex is a trademark of Novartis
Foradil* (formoterol fumarate)
Bronchodilator
Consumer Information [85]
Product Monograph [86]
Important information for healthcare professionals (2005) [87]
*Foradil is a registered trademark
G [88]
Gilenya* (fingolimod (as fingolimod hydrochloride))
Sphingosine 1-phosphate receptor modulator
Consumer Information [89]
Product Monograph [90]
Important information for healthcare professionals (2012) [91]
Public Communication (2012) [92]
Health Product Risk Communication (2019) [93]
www.gilenya.ca [94]
*Gilenya is a registered trademark
Gleevec* (imatinib mesylate)
Protein Kinase Inhibitor
Consumer Information [95]
Product Monograph [96]
Important information for healthcare professionals (2009) [97]
Fact Sheet (2009) [98]
Important information for healthcare professionals (2006) [99]
Public Communication (2006) [100]
Important information for healthcare professionals and patients (2016) [101]
*Gleevec is a registered trademark
I [102]
IZBA* (Travoprost ophthalmic solution)
Elevated Intraocular Pressure Therapy
Patient Medication Information [103]
Product Monograph [104]
*IZBA is a trademark of Novartis
Ilaris* (canakinumab)
Immunomodulator
Consumer Information [105]
Product Monograph [106]
*Ilaris is a registered trademark
Ilevro* (nepafenac)
Nonsteroidal Anti-Inflammatory
Product Monograph [107]
Consumer Information [108]
*Ilevro is a Novartis product
Iopidine* (apraclonidine)
Antiglaucoma Preparations and Miotics
Patient Medication Information [109]
Product Monograph [110]
*Iopidine is a trademark of Novartis
Isopto* Carpine (pilocarpine hydrochloride)
Parasympathomimetic
Consumer Information [111]
Product Monograph [112]
*Isopto is a trademark of Novartis
J [113]
Jadenu* (Deferasirox)
Iron Chelating Agent
Consumer Information [114]
Product Monograph [115]
Important information for healthcare professionals (2016) [116]
*Jadenu is a trademark
Jakavi* (ruxolitinib)
Antineoplastic Agent
Consumer Information [117]
Product Monograph [118]
*Jakavi is a registered trademark
K [119]
Kisqali* (ribociclib)
Protein Kinase Inhibitor
Patient Medication Information [120]
Product Monograph [121]
*Kisqali is a trademark
Kymriah* (Tisagenlecleucel)
Antineoplastic and immunomodulating agents
Patient Medication Information [122]
Product Monograph [123]
*KYMRIAH is a trademark
L [124]
Lamisil* (terbinafine hydrochloride)
Antifungal Agent
Consumer Information [125]
Product Monograph [126]
Important information for healthcare professionals (2001) [127]
*Lamisil is a registered trademark
Lescol* XL (fluvastatin sodium)
Lipid Metabolism Regulator
Consumer Information [128]
Product Monograph [129]
*Lescol is a registered trademark
Lioresal* (baclofen)
Antispastic Agent
Consumer Information [130]
Product Monograph [131]
*Lioresal is a registered trademark
Lioresal* Intrathecal (baclofen injection)
Antispastic Agent
Consumer Information [132]
Product Monograph [133]
*Lioresal is a registered trademark
Lopresor* / Lopresor SR* (metoprolol tartrate)
B - Adrenergic Receptor Blocking Agent
Consumer Information [134]
Product Monograph [135]
*Lopresor and Lopresor SR are registered trademarks
Lucentis* (ranibizumab injection)
Antineovascularisation agent
Consumer Information [136]
Product Monograph [137]
*Lucentis is a registered trademark
M [138]
Maxidex* (dexamethasone)
Corticosteroid
Consumer Information [139]
Prescribing Information [140]
*Maxidex is a trademark of Novartis
Maxitrol* (neomycin, polymyxin B sulfates and dexamethasone)
Anti-inflammatory/Antibiotic
Consumer Information [141]
Prescribing Information [142]
*Maxitrol is a trademark of Novartis
Mayzent* (siponimod)
Sphingosine 1-phosphate receptor modulator
Product Monograph [143]
Patient Medication Information [144]
*MAYZENT is a trademark
Mekinist* (Trametinib Tablets)
Protein Kinase Inhibitor
Consumer Information [145]
Product Monograph [146]
*MEKINIST is a registered trademark
Myfortic* (mycophenolic acid (as mycophenolate sodium))
Immunosuppressant
Consumer Information [147]
Product Monograph [148]
Important information for healthcare professionals (2009) [149]
Public Communication (2009) [150]
Important information for health care professionals (2016) [151]
*Myfortic is a registered trademark
N [152]
Neoral* (cyclosporine)
Immunosuppressant
Consumer Information [153]
Product Monograph [154]
Neoral* Oral Solution-Recall Notice Lot H5131-January 2013 [155]
Recall of Lot H5131-Return Process-January 2013 [156]
*Neoral is a registered trademark
Nevanac* (nepafenac)
Nonsteroidal Anti-Inflammatory
Consumer Information [157]
Product Monograph [158]
*a trademark of Novartis
O [159]
Onbrez* Breezhaler* (indacaterol maleate)
Long-acting beta2-agonist
Consumer Information [160]
Product Monograph [161]
*Onbrez and Breezhaler are registered trademarks
P [162]
Pataday* (Olopatadine Hydrochloride)
Anti-allergy Agent
Consumer Information [164]
Product Monograph [165]
*Pataday is a registered trademark of Novartis
Patanol* (Olopatadine Hydrochloride)
Anti-allergy Agent
Consumer Information [166]
Product Monograph [167]
*Patanol is a Registered trademark of
Pazeo* (olopatadine)
Anti-allergy Agent
Patient Medication Information [168]
Product Monograph [169]
*Pazeo is a trademark of Novartis
Piqray* (Alpelisib)
Antineoplastic Agent
Patient Medication Information [170]
Product Monograph [171]
*PIQRAY is a registered trademark
R [172]
Revolade* (Eltrombopag)
Thrombopoietin Receptor Agonist
Consumer Information [173]
Product Monograph [174]
Important information for healthcare professionals (2016) [175]
*REVOLADE is a registered trademark
Ritalin* (methylphenidate hydrochloride)
Central Nervous System Stimulant
Consumer Information [176]
Product Monograph [177]
Public Communication (2015) [178]
*Ritalin is a registered trademark
Rydapt* (midostaurine)
Antineoplastic Agent
Consumer Information [179]
Product Monograph [180]
*Rydapt is a trademark
S [181]
Sandimmune* I.V. (cyclosporine)
Immunosuppressant
Consumer Information [182]
Product Monograph [183]
*Sandimmune is a registered trademark
Sandostatin* / Sandostatin* LAR* (octreotide acetate injection) / (octreotide as acetate for injectable suspension)
Synthetic Octapeptide Analogue of Somatostatin
Consumer Information [184]
Product Monograph [185]
*Sandostatin and LAR are registered trademarks
Seebri* Breezhaler* (glycopyrronium bromide)
Long-acting muscarinic antagonist
Consumer Information [186]
Product Monograph [187]
*Seebri and Breezhaler are registered trademarks
Simbrinza* (brinzolamide / brimonidine tartrate)
Topical Carbonic Anhydrase Inhibitor and Topical Alpha-2 Agonist Agent
Consumer Information [188]
Product Monograph [189]
*Simbrinza is a Novartis product
Simulect* (basiliximab)
Immunosuppressant
Consumer Information [190]
Product Monograph [191]
*Simulect is a registered trademark
Stalevo* (levodopa, carbidopa and entacapone)
Anti-parkinsonian Dopaminergic Agent
Consumer Information [192]
Product Monograph [193]
*Stalevo is a registered trademark
T [194]
Tafinlar* (Dabrafenib (as dabrafenib mesylate))
Protein Kinase Inhibitor
Consumer Information [195]
Product Monograph [196]
Important information for healthcare professionals (2015) [197]
*TAFINLAR is a registered trademark
Tasigna* (nilotinib)
Protein-tyrosine Kinase Inhibitor
Consumer Information [198]
Product Monograph [199]
Important information for healthcare professionals (2013) [200]
Public Communication (2013) [201]
Important information for healthcare professionals (2011) [202]
Fact sheet (2011) [203]
Important information for healthcare professionals (2010) [204]
Fact Sheet (2010) [205]
Important information for healthcare professionals and patients (2016) [101]
*Tasigna is a registered trademark
Tegretol* (carbamazepine)
Anticonvulsant, Antimanic, For Symptomatic Relief Of Trigeminal Neuralgia
Consumer Information [206]
Product Monograph [207]
Important information for healthcare professionals (2008) [208]
*Tegretol is a registered trademark
TobraDex* (Tobramycin and Dexamethasone)
Antibacterial and Corticosteroid
Patient Medication Information [209]
Product Monograph including Patient Medication Information [210]
*Tobradex is a trademark of Novartis
Tobrex* (Tobramycin)
Antibacterial (ophthalmic)
Product Monograph [211]
Patient Medication Information [212]
*Tobrex is a trademark of Novartis
Transderm-Nitro* (nitroglycerin)
Antianginal Agent
Consumer Information [213]
Product Monograph [214]
*Transderm-Nitro is a registered trademark
Travatan* Z (Travoprost)
Prostaglandin F2a analogue
Patient Medication Information [215]
Product Monograph including Patient Medication Information [216]
*Travatan is a trademark of Novartis
Triesence* (triamcinolone acetonide)
Visualization Agent
Consumer Information [217]
Product Monograph [218]
*Triesence is a trademark of Novartis
Trileptal* (oxcarbazepine)
Antiepileptic
Consumer Information [219]
Product Monograph [220]
Important information for healthcare professionals (2005) [221]
*Trileptal is a registered trademark
Tykerb* (lapatinib tablets (as lapatinib ditosylate))
Antineoplastic Agent
Consumer Information [222]
Product Monograph [223]
Important information for healthcare professionals [224]
Public Communication (2013) [225]
*TYKERB is a registered trademark
U [226]
Ultibro* Breezhaler* (indacaterol maleate and glycopyrronium bromide)
Long-acting beta2-agonist and Long-acting muscarinic antagonist
Consumer Information [227]
Product Monograph [228]
*Ultibro and Breezhaler are registered trademarks
V [229]
Vigamox* (Moxifloxacin Ophtalmic Solution)
Antibacterial (ophtalmic)
Consumer Information [230]
Product Monograph [231]
*a trademark of Novartis
Voltaren Rapide* (diclofenac potassium)
Nonsteroidal Anti-Inflammatory Drug (NSAID)
Consumer Information [232]
Product Monograph [233]
Important information for healthcare professionals (2014) [234]
Public Communication (2014) [235]
*Voltaren Rapide is a registered trademark
Voltaren* / Voltaren* SR (diclofenac sodium)
Nonsteroidal Anti-Inflammatory Drug (NSAID)
Consumer Information [236]
Product Monograph [237]
Important information for healthcare professionals (2014) [238]
Public Communication (2014) [239]
*Voltaren is a registered trademark
Voltaren* Ophtha (Diclofenac Sodium)
Anti-inflammatory Analgesic Agent
Consumer Information [240]
Product Monograph [241]
*Voltaren is a trademark of Novartis
Votrient* (Pazopanib (as pazopanib hydrochloride))
Antineoplastic Agent
Consumer Information [242]
Product Monograph [243]
Important information for healthcare professionals (2013) [244]
Public Communication (2013) [245]
*VOTRIENT is a registered trademark
X [246]
Xiidra* (Lifitegrast)
Lymphocyte function associated antigen-1 (LFA-1) antagonist
Patient Medication Information [247]
Product Monograph [248]
*XIIDRA is a registered trademark
Xolair* (omalizumab)
IgE-Neutralizing Antibody (Anti-IgE)
Consumer Information [249]
Product Monograph [250]
*Xolair is a registered trademark
Z [251]
Zofran* / Zofran* ODT ((ondansetron hydrochloride dihydrate))
Antiemetic
Consumer Information [252]
Product Monograph [253]
Important information for healthcare professionals (2014) [254]
Important information for healthcare professionals (2012) [255]
Public Communication (2012) [256]
*ZOFRAN is a registered trademark
Zometa* (zoledronic acid for injection)
Bone Metabolism Regulator
Consumer Information [257]
Product Monograph [258]
Important information for healthcare professionals (2005) [259]
Public Communication (2005) [260]
Important information for healthcare professionals (2004) [261]
*Zometa is a registered trademark
Zykadia* (Ceritinib)
Protein Kinase Inhibitor
Consumer Information [262]
Product Monograph [263]
Important information for healthcare professionals (2015) [264]
*ZYKADIA is a registered trademark